SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...
The Food and Drug Administration said Monday not to use Cue Health’s COVID-19 tests because of an increased risk of false results. FDA inspectors found Cue made unauthorized changes to its COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results